Cargando…
The epidemiology and therapeutic options for the COVID-19
An outbreak of coronavirus disease 2019 (COVID-19), a disease caused by a novel pneumonia virus, has affected over 200 countries and regions worldwide. With the increasing number of patients and deaths, WHO have declared it as a global pandemic currently, indicating a third large-scale epidemic coro...
Autores principales: | Li, Jingwei, Shao, Jun, Wang, Chengdi, Li, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376264/ https://www.ncbi.nlm.nih.gov/pubmed/35960683 http://dx.doi.org/10.1093/pcmedi/pbaa017 |
Ejemplares similares
-
The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis
por: Qiu, Rong, et al.
Publicado: (2021) -
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
por: Li, Jingwei, et al.
Publicado: (2023) -
Cryptococcal meningitis: epidemiology and therapeutic options
por: Sloan, Derek J, et al.
Publicado: (2014) -
Potential Therapeutic Options for COVID-19
por: Zheng, Xiaoqin, et al.
Publicado: (2020) -
A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patients
por: Shao, Jun, et al.
Publicado: (2020)